Development of Ingestible Biosensors to Enhance PrEP Adherence in Substance Users (PrEPSteps)

Clinical trial NCT03512418 · COMPLETED

Trial details

NCT number: NCT03512418
Sponsor: Brigham and Women's Hospital
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

HIV Infections Substance Use Disorders

Start date: 2019-06-20
Primary completion: 2024-04-10
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.